Biotech · Private company
Kiadis Pharma
Track this companyFree. Adds Kiadis Pharma to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- ATIR101Phase 3 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 3 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- Donor lymphocyte preparation depleted of host functional alloreactive T-cellsPhase 3 · Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- T-cell depleted HSCT from a related, haploidentical donorPhase 3 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- T-cell replete HSCT from a related, haploidentical donorPhase 3 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- Conditioning RegimenPhase 2 · Acute Myeloid Leukemia (AML)ClinicalTrials.gov · fetched Nov 12, 2026
- HaploBMTPhase 2 · Acute Myeloid Leukemia (AML)ClinicalTrials.gov · fetched Nov 12, 2026
- K-NK002Phase 2 · Acute Myeloid Leukemia (AML)ClinicalTrials.gov · fetched Nov 12, 2026
- NB1011Phase 2 · TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Haplo-identical Natural Killer (NK) Cells to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)PHASE2 · WITHDRAWN · started Nov 13, 2020ClinicalTrials.gov NCT04395092 · fetched Nov 12, 2026
- Trial Testing Safety of IL-21 NK Cells for Induction of R/R AMLPHASE1 · COMPLETED · started Jun 11, 2020ClinicalTrials.gov NCT04220684 · fetched Nov 12, 2026
- Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood CancerPHASE3 · TERMINATED · started Nov 29, 2017ClinicalTrials.gov NCT02999854 · fetched Nov 12, 2026
- Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical DonorPHASE2_PHASE3 · TERMINATED · started Aug 1, 2009ClinicalTrials.gov NCT00967343 · fetched Nov 12, 2026
- NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)PHASE1_PHASE2 · COMPLETED · started Sep 1, 2005ClinicalTrials.gov NCT00248404 · fetched Nov 12, 2026